Fidelity
Home > Boards > US OTC > Medical - Healthcare >

Revolutions Medical Corp. (RMCP)

RMCP RSS Feed
Add RMCP Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 11/25/2013 7:19:21 AM - Followers: 16 - Board type: Free - Posts Today: 0

About Revolutions Medical Product - RMCP

Revolution Medical's products include the Rev Vac safety syringe, safety blood drawing device and safety IV catheter. The world market for safety-engineered medical devices (SEMDs) is projected to exceed 2 billion this year and is forecasted to maintain a 20% annual growth rate in the near term. Revolutions Medical also provides software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software includes sorting of images, color, 3D, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion. The Rev Vac safety syringe and the Rev ColorMRI have not yet been cleared by the FDA for sale in the United States.

Rev ColorMRI

Since inception, the Company’s principal business has been to complete the development of and to commercialize color MRI Technology. The technology consists of software, which uses various color masks to produce full-color composite images from gray-scale MRI output. The resulting color images can be quickly viewed individually or all together as a “riffle stack”.

A riffle stack consists of the individual MRI images assembled to create a single composite image that contains the data from the individual images. The riffle stack allows a radiologist, using a computer mouse, to page through the images, creating a 3-D appreciation of the colorized MRI output even though the images themselves are not 3-D.

The software program can also segment the data and create a true 3-D image of the area to be examined. For instance, bone, fluid and other tissue displayed in an MRI scan of the head can be electronically eliminated to allow a 3-D rendering of just the brain.

The color images can be transferred to a CD-ROM or other digital storage device, instead of bulky film, for storage or for a patient to take to their referring physician. Because the color images are transferred to digital storage in a standard *.jpeg format, the color images can be viewed on any PC without the need for special software. The Rev ColorMRI has not yet been cleared by the FDA for sale in the United States.

Color MRI Video: http://www.revolutionsmedical.com/RevMed-ColorMRI-Video.php

Rev Vac Safety Syringe

The Rev Vac Safety Syringe and Phlebotomy (blood drawing) Device operate the same as a standard syringe and device. No additional training, skills, or procedures are necessary. The both products work on a vacuum principle, where pressing the plunger in them creates a vacuum. When the plunger reaches the bottom, the needle is captured. A further push on the plunger breaks the seal, and the needle retracts into the plunger barrel. The vacuum is maintained, so the needle cannot be removed from the plunger.

Revolutions Medical owns the patents and will manufacture a disposable retractable syringe and phlebotomy device. The products use a proprietary patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn. Prototype units have been produced and tested, but no units have been manufactured. The products have been designed to be manufactured at a cost that is approximately equal to the cost of traditional disposable syringes and phlebotomy devices and are intended to be a safe replacement for existing non-safe syringes and phlebotomy devices and even currently marketed syringes and devices labeled as safety products.

With traditional syringes and phlebotomy devices, a needle contaminated with a patient’s blood remains a danger to healthcare professionals handling the needle until it is permanently disposed of in a proper biohazard containment unit. Revolutions Medical’s safety products do not present a “needlestick” hazard to health professionals after use because the contaminated needle is retracted into the barrel of the safety product and locked in place. The Rev Vac safety syringe has not yet been cleared by the FDA for sale in the United States.

Safety Syringe Video: http://www.revolutionsmedical.com/RevMed-RevVacSafetySyringe.php

 

Management

Rondald Wheet - CEO, Chairman of the Board
Mr. Wheet has over fifteen (15) years experience in the investment banking industry and while working for several NASD registered broker dealers has raised in excess of $100 million for small cap companies. He held five licenses with the NASD; series 4, 7, 24, 63, and 65.  He operated in a management and principal capacity for 10 years during that time and was a compliance officer for 2 years. He worked for investment firms such as Cohig & Associates, Scott and Stringfellow, Fortress Financial, and RichMark Capital. He was in charge of opening up three different brokerage offices from the beginning, including finding ideal office space, hiring personnel, becoming NASD compliant and turning them into successful branch offices.  He started his own consulting business in 2002, Mansfield Garrett, Inc., and worked with many start up and micro cap companies; giving advice on capital raising, strategic partnerships, stock awareness, hiring top management  and going to the public market. He served on the Board of Directors for Clear Image, Inc. since 2004. Ron is past President of the Metropolitan Exchange Club of Charleston, SC. He received a Bachelor of Science degree from the University of Towson in both Finance and International Business in 1987.

Thomas O’Brien - President
Mr. O’Brien has more than twenty (20) years of general management experience in the medical device industry. He has special expertise in domestic and international sales, marketing and distribution of high technology medical systems and services. He has held executive positions with medical industry leaders such as Pfizer, Toshiba, and Johnson and Johnson owned Technicare Corporation. In 1995 he joined Spectrum Technology, a cosmetic laser company, as Vice President of Sales and Marketing. Spectrum was acquired by Palomar Corporation in 1996, and Mr. O’Brien went on to become Executive President for all of the Palomar companies. In 1996/1997 he became the President and CEO of Cosmetic Technology International, a cosmetic laser center business operating worldwide. He has most recently been the President and CEO of BioTrack, Inc. which has developed a device for the localization of breast cancer. He has also been CEO of Medical Online, Inc., an online internet medical consulting company. He has received a B.S. in foreign languages from the University of Maryland, served in the U.S. Air Force Security Service and also at the National Security Agency as a Chinese linguist.

Finalcials Dec 4th, 2008

http://finance.yahoo.com/q/is?s=rmcp.ob 

Press Releases

Revolutions Medical Filed for Patent Protection in Europe for its Pending MRI PatentsBusiness Wire(Wed 10:08am)

REVOLUTIONS MEDICAL CORP FinancialsEDGAR Online Financials(Thu, Dec 4)

Revolutions Medical Completes Merger with Clear ImageBusiness Wire(Tue, Dec 2)

REVOLUTIONS MEDICAL CORP Files SEC form 8-K, Other EventsEDGAR Online(Mon, Dec 1)

Revolutions Medical Patent NewsBusiness Wire(Thu, Nov 20)

Revolutions Medical Corporation Files Pre Market 510K Application with the FDA for 3cc Rev Vac Safety SyringeBusiness Wire(Tue, Oct 28)

REVOLUTIONS MEDICAL CORP FinancialsEDGAR Online Financials(Thu, Sep 11)

Revolutions Medical Signs Contract for Rev Vac Manufacturing Service with Strategic Product Development, Inc.Business Wire(Thu, Sep 11)

Revolutions Medical Begins Manufacturing Selection Process for the Rev Vac Safety SyringeBusiness Wire(Tue, Sep 9)

REVOLUTIONS MEDICAL CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Aug 21)

Revolutions Medical Finishes Filing Its International Patent Protection for the Rev Vac Safety SyringeBusiness Wire(Thu, Aug 21)

REVOLUTIONS MEDICAL CORP FinancialsEDGAR Online Financials(Thu, May 1)

REVOLUTIONS MEDICAL CORP Files SEC form 10KSB, Annual ReportEDGAR Online(Thu, Apr 24)

 

Share Data
Authorized Outstanding
Date Shares Source Date Shares Source
11/29/2006 250,000,000 DEF 14C 07/28/2008 21,075,273 MGFS
         
  From Recent 10Q  

As of the date of this report, we had a total of 10,292,500 options and warrants outstanding, which consisted of options to purchase up to 10,185,000 shares of common stock at exercise prices ranging from $0.08 to $10.00 per share(of which all were exercisable) and warrants to purchase up to 107,500 shares of common stock at an exercise price of $5.00 per share (all of which were exercisable). All of the options and warrants outstanding are presently "out of the money", meaning that the exercise price is greater than the current market price of our common stock. We may decide, however, to modify the terms and/or exercise price of these "out of the money" options and warrants. To the extent that the outstanding options and warrants to purchase our common stock are exercised, your ownership interest may be diluted. If the warrants and options are exercised and sold into the market, they could cause the market price of our common stock to decline.


As of June 30, 2008, the Company had 250,000,000 shares authorized and 20,717,388 shares outstanding. The authorized but unissued shares have the same rights and privileges as the common stock presently outstanding. The unissued authorized shares can be issued without further action of the shareholders. If and when, and to the extent that, the unissued authorized shares are issued and sold into the market, they could cause the market price of our common stock to decline.

 


 

 

Contact Info

Website: http://www.revolutionsmedical.com

INVESTMENT
investment@revolutionsmedical.com
Scott Key: 843-408-6265

 

CORPORATE HEADQUARTERS
2073 Shell Ring Circle
Mount Pleasant, SC 29466
843-971-4848 office
843-971-6917 fax

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RMCP
Current Price
Volume:
Bid Ask Day's Range
Wiki
PostSubject
#357   RMCP's former accountants, Hood & Associates, and audit jurisper 11/25/13 07:19:21 AM
#356   CAVEAT EMPTOR silvergun 09/11/13 03:26:56 PM
#355   http://imgweb.charlestoncounty.org/CMSOBView/Service1.asmx/StreamDocAsPDF?viewer lucky,mydog 07/01/13 08:36:24 PM
#354   http://www.sec.gov/litigation/complaints/2012/comp22489.pdf lucky,mydog 07/01/13 07:38:11 PM
#353   U.S. SECURITIES AND EXCHANGE COMMISSION lucky,mydog 07/01/13 07:37:18 PM
#352   $20 Million Awarded in Internet Libel Case AlanC 07/01/13 07:05:46 PM
#351   They need cash to operate, this is somewhat CEOA1US 06/21/13 04:08:27 PM
#350   What do u think of this new deal silvergun 06/21/13 10:30:14 AM
#349   thats because they are typically run by ego CEOA1US 06/07/13 09:10:12 AM
#348   Yea just too bad. Oh well. Most pennies silvergun 06/07/13 09:02:25 AM
#347   True enough but thats because the CEO runs CEOA1US 06/07/13 08:59:59 AM
#346   Plus as u can see from our posts silvergun 06/07/13 08:16:54 AM
#345   Yea I guess you were correct. I just silvergun 06/07/13 07:56:27 AM
#344   Silvergun, did you see that the CEO has CEOA1US 06/07/13 07:53:05 AM
#343   Silvergun, you obviously don't know how asher operates CEOA1US 05/24/13 10:51:17 AM
#342   All cos have to raise $. silvergun 05/23/13 12:01:45 PM
#341   Here's from the most recent 10Q they are CEOA1US 05/22/13 09:51:50 AM
#340   Read the 10K. Page 34 CEOA1US 05/22/13 09:46:32 AM
#339   Really ? Asher ? U have any proof silvergun 05/21/13 06:31:28 PM
#338   Unfortunately they have a lot of loans out CEOA1US 05/21/13 03:09:02 PM
#337   Nice sale today. 12 million to Brazil. Lets silvergun 05/21/13 11:45:06 AM
#336   Clearly you've never done business with either Cardinal CEOA1US 04/29/13 03:52:02 PM
#335   No. I expect to see sales sometime this silvergun 04/26/13 09:01:37 AM
#334   They signed these deals months ago and yet CEOA1US 04/25/13 08:13:32 PM
#333   Well that's the goal. It's a penny stock. silvergun 04/25/13 08:30:12 AM
#332   Problem is that they probably have no sales. CEOA1US 04/24/13 05:55:43 PM
#331   Deal w McKesson $90 a share co Now silvergun 01/15/13 08:31:16 AM
#330   someone said merger? what merger OCMillionare 11/20/12 09:26:31 AM
#329   Yup..looking REAL good and best part is it Xtreme81 11/19/12 11:25:43 PM
#328   My .10's look nice...wish I had bought more. retireat40 11/19/12 02:17:55 PM
#327   ahem....lol 89% today OCMillionare 11/19/12 01:39:57 PM
#326   WEEEEEEEEEEEEEEE OCMillionare 11/19/12 11:40:27 AM
#325   Very nice so far:) retireat40 11/19/12 11:08:39 AM
#324   Happy ;) OCMillionare 11/19/12 11:08:06 AM
#323   And as I was typing...we got a nice Xtreme81 11/19/12 10:45:05 AM
#322   Looking good..nice buys and up nearly 50% already :) Xtreme81 11/19/12 10:44:05 AM
#321   RMCP here we go!! a few more hours OCMillionare 11/19/12 02:19:26 AM
#320   Upper Bollie is .108. Break that and 50DMA retireat40 11/17/12 11:00:51 AM
#319   I bought a nice starter today...looks is terrific! Xtreme81 11/16/12 03:14:38 PM
#318   Not having much impact...news has yet to catch retireat40 11/16/12 02:56:44 PM
#317   DISTRIBUTION AGREEMENT WITH COMPANY TRADING AT $90!! Gutter92 11/16/12 02:32:19 PM
#316   News!! Gutter92 11/16/12 02:32:03 PM
#315   Check out todays news. Distro agreement w McKesson silvergun 11/16/12 01:45:39 PM
#314   Looks like this is heading back in the CEOA1US 11/13/12 05:24:41 PM
#313   Yea they already moved from .05 to .12 silvergun 10/23/12 07:46:17 AM
#312   Agreed. When they get off and running - MarcWane 10/23/12 12:25:55 AM
#311   Sec charge is re old news. Co suing silvergun 10/17/12 07:25:45 PM
#310   Might be a bit early take this as MarcWane 09/29/12 09:42:01 AM
#309   Wheels are falling off the bus. SEC fraud willlbone 09/26/12 09:43:09 AM
#308   SEC CHARGES REVOLUTIONS MEDICAL CORP. AND ITS CEO scion 09/21/12 06:36:56 PM
PostSubject